The Group is a significant player in South Asia in the research, marketing, sale and manufacture of pharmaceuticals, APIs and biotechnology products in several therapeutic groups with global exports and highly successful long-term international collaborations with leading global majors. The Group expects significant growth in the future from the strengthening Indian economy, entry into new therapeutic groups and geographies, an increasing pipeline of research products, and the Group’s global cost competitiveness in manufacturing and research and development for the pharmaceutical, bulk drugs and biotechnology industries.